Uzbekistan and Malaysia: New Investment Projects in the Biopharmaceutical Sector Discussed
Uzbekistan and Malaysia: New Investment Projects in the Biopharmaceutical Sector Discussed
Abdulla Azizov, Director of the Agency for the Development of the Medical and Pharmaceutical Industry, held a meeting with Datuk Mohd Ghazali Bin Hj Ahmad, founder of the Malaysian company GREENTACT HEALTHCARE SDN. BHD.
The meeting discussed issues related to expanding cooperation between Uzbekistan and Malaysia in the biopharmaceutical sector, localizing high-tech production, and implementing new investment projects.
In particular, special attention was paid to the prospects of establishing local production in Uzbekistan of insulin and its analogues, as well as vaccines against human papillomavirus (HPV), introducing modern technologies, and implementing joint projects.
The guests were provided with information about the potential of the "BioPharma City" pharmaceutical cluster, modern production and research infrastructure, conditions created for investors, as well as tax and customs incentives.
These initiatives will contribute to expanding the production of high-tech products in the biopharmaceutical sector in Uzbekistan, increasing the range of import-substituting products, and strengthening international investment cooperation.
Related materials
Submit an online request for pharmaceutical services
Get in touch to submit a request and use Pharm Service offerings.